Myelofibrosis Plasma
Myelofibrosis Plasma - Cryopreserved human plasma collected from clinically confirmed myelofibrosis donors. Myelofibrosis plasma is ideal for biomarker discovery, understanding disease progression, and therapeutic development.
| Lot # | Condition | Volume | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 78977 | Myelofibrosis | 1.0 ML | 51 | Female | Ukraine |
L-thyroxine, Hydroxycarbamide
|
1 | $667.00 | ||
| 78978 | Myelofibrosis | 1.0 ML | 51 | Female | Ukraine |
L-thyroxine, Hydroxycarbamide
|
1 | $667.00 | ||
| 78979 | Myelofibrosis | 1.0 ML | 51 | Female | Ukraine |
L-thyroxine, Hydroxycarbamide
|
1 | $667.00 | ||
| 78980 | Myelofibrosis | 1.0 ML | 51 | Female | Ukraine |
L-thyroxine, Hydroxycarbamide
|
1 | $667.00 | ||
| 78981 | Myelofibrosis | 1.0 ML | 51 | Female | Ukraine |
L-thyroxine, Hydroxycarbamide
|
1 | $667.00 | ||
| 78982 | Myelofibrosis | 1.0 ML | 51 | Female | Ukraine |
L-thyroxine, Hydroxycarbamide
|
1 | $667.00 | ||
| 78983 | Myelofibrosis | 1.0 ML | 51 | Female | Ukraine |
L-thyroxine, Hydroxycarbamide
|
1 | $667.00 | ||
| 78984 | Myelofibrosis | 1.0 ML | 51 | Female | Ukraine |
L-thyroxine, Hydroxycarbamide
|
1 | $667.00 | ||
| 78985 | Myelofibrosis | 1.0 ML | 51 | Female | Ukraine |
L-thyroxine, Hydroxycarbamide
|
1 | $667.00 | ||
| 78974 | Myelofibrosis | 1.0 ML | 51 | Female | Ukraine |
L-thyroxine, Hydroxycarbamide
|
1 | $667.00 |
Myelofibrosis Plasma | High-Quality Human Plasma from Myelofibrosis Donors
Myelofibrosis Plasma is collected from donors clinically diagnosed with myelofibrosis and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research in cytokines, growth factors, and circulating tumor DNA (ctDNA) in myelofibrosis pathogenesis.
Product Features
- Research Use Only (RUO)
- Plasma collected from clinically confirmed myelofibrosis donors
- Processed within one day of collection
- IRB-approved protocols and informed consent
- Custom aliquot volumes available upon request
De-identified Donor Data
- Verified myelofibrosis diagnosis
- Demographic data: age, sex assigned at birth, race/ethnicity
- Donor-reported medications, allergies, and comorbidities
- Additional myelofibrosis-specific metadata available
Applications
- Biomarker discovery and validation
- Cytokine and inflammation profiling
- Metabolomics and proteomics studies
- Therapeutic response research
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Myelofibrosis plasma is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Protocols & Documentation
-
Download
Plasma Isolation
Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Plasma
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – all our products are research use only (RUO).
1 Answer
You can find our full product catalog here.
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: Quality and Compliance
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Plasma cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.